De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
about
Safety of mTOR inhibitors in adult solid organ transplantation.Therapeutic plasma exchange in children: one center's experience.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Thrombotic microangiopathy after renal transplantation: Current insights in and recurrent diseaseDrug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
P2860
De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@ast
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@en
type
label
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@ast
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@en
prefLabel
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@ast
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@en
P2093
P2860
P1433
P1476
De novo tacrolimus-induced thr ...... with conversion to everolimus.
@en
P2093
Gerard Cortina
Johannes Hofer
Nadezda Gut
Raphaela Trojer
Siegfried Waldegger
Stefan Schneeberger
P2860
P2888
P304
P356
10.1007/S00467-014-3036-8
P577
2015-01-12T00:00:00Z
P5875
P6179
1052661621